Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
280 participants
INTERVENTIONAL
2006-03-31
2006-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This is a multicenter observational-interventional study on critically ill patients who require mechanical ventilation for more than 48 hours, involving 13 ICU in Chile. There are two periods (groups): a descriptive phase of sedation practices, and an interventional period in which an analgesia-based, goal-directed, nurse-driven sedation is applied.
Main outcome: ventilator-free days between both periods.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Main exclusion criteria are neurologic impairment, previous chronic cardiac, liver and renal failure, second period of mechanical ventilation during hospitalization, short term expected mortality.
There is an initial descriptive phase of sedation practice, involving sedative drugs, sedation level assessment, and outcome: ventilator-free days, ICU stay, costs and mortality.
After a period of analysis and training, an analgesia-based, goal-directed, nurse-driven sedation protocol is applied. Fentanyl infusion is started and titrated to obtain a patient calm and cooperative or mildly sedated while on mechanical ventilation. Hypnotics and opiates i.v. boluses are allowed during the first hours of mechanical ventilation. Midazolam infusion is started if ventilatory distress continue despite fentanyl 1.8 µg/kg/min. Haldol, muscle relaxants and other sedative drugs are allowed depending on patient condition. After 48 hours of mechanical ventilation, sedative drugs are discontinued in the morning.
Main outcome: ventilator-free days. Secondary outcome: ICU stay, costs, and sedation quality. At 6 moths SF-36. Each period is planned to included at least 140 patients, for a 20% difference in ventilator-free days, with 80% power and a 0.05 type I error.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Analgesia based sedation in ICU patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Previous liver or renal failure
* Second episode of MV during same hospitalization
* Expected MV shorter than 48 hours
* Short term expected mortality.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pontificia Universidad Catolica de Chile
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guillermo Bugedo, MD
Role: PRINCIPAL_INVESTIGATOR
Universidad Catolica de Chile
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Regional de Coquimbo
Coquimbo, , Chile
Hospital Universidad Catolica de Chile
Santiago, , Chile
Clinica Alemana
Santiago, , Chile
Hospital Clinico Universidad de Chile
Santiago, , Chile
Hospital Dipreca
Santiago, , Chile
Hospital Luis Tisne
Santiago, , Chile
Hospital Militar
Santiago, , Chile
Hospital Padre Hurtado
Santiago, , Chile
Hospital San Jose
Santiago, , Chile
Hospital San Juan de Dios
Santiago, , Chile
Hospital Sotero del Rio
Santiago, , Chile
Hospital Regional de Talca
Talca, , Chile
Hospital Carlos Van Buren
Valparaíso, , Chile
Hospital Naval
Viña del Mar, , Chile
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hector Ugarte
Role: primary
Guillermo Bugedo
Role: primary
Eduardo Tobar
Role: backup
Vinko Tomicic
Role: primary
Jose Castro
Role: primary
Jose Castro
Role: primary
Pilar Lora
Role: primary
Antonio Hernandez
Role: primary
Hugo Gonzalez
Role: primary
Jorge Godoy
Role: primary
Juan Jara
Role: primary
Eduardo Encalada
Role: primary
Eduardo Labarca
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SA05I20091
Identifier Type: -
Identifier Source: org_study_id